Atara Biotherapeutics (ATRA) Change in Inventory (2022 - 2025)

Atara Biotherapeutics (ATRA) has reported Change in Inventory for 4 consecutive years, with -$10.7 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Change in Inventory fell 267.06% year-over-year to -$10.7 million; the trailing twelve-month figure through Dec 2025 stood at -$10.7 million (down 340.3% YoY), and the FY2025 full-year result was -$10.7 million, down 340.3% from the prior year.
• Change in Inventory declined to -$10.7 million in Q1 2025 per ATRA's latest filing, from $160000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $6.4 million in Q1 2024 and bottomed at -$10.7 million in Q1 2025.
• Historically, Change in Inventory has averaged $348500.0 across 4 years, with a median of $2.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 96.41% in 2023, then tumbled 275.51% in 2024.
• Over 4 years, Change in Inventory stood at $1.6 million in 2022, then surged by 96.41% to $3.1 million in 2023, then plunged by 94.86% to $160000.0 in 2024, then slumped by 6759.38% to -$10.7 million in 2025.
• According to Business Quant data, Change in Inventory over the past three periods registered -$10.7 million, $160000.0, and -$4.8 million for Q1 2025, Q4 2024, and Q3 2024 respectively.